Saba Capital Management, L.P. bought HQL
June 13, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 8,467 shares of Abrdn Life Sciences Investors at $13.82 per share, a transaction worth $117.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
8,467
Price
$13.82
Total value
$117.0K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 13, 2024
Filing dateJune 14, 2024
Shares owned after3,416,079
OwnershipIndirect
10b5-1 planNo
AmendedNo